BoomerangFX Expands Operations in the UK and EMEA, Emphasizing AI-Driven Clinical Support
BoomerangFX Expands Operations in the UK and EMEA
BoomerangFX, a global leader in AI-powered clinical software and marketing automation, has recently launched a new office in the United Kingdom. This expansion is a response to an unprecedented 6,000% year-over-year growth recorded in 2025, particularly in private-pay healthcare practices across England, Wales, Ireland, Scotland, and the broader EMEA region.
The company's founder and CEO, Jerome Dwight, leads BoomerangFX from its established offices in Miami, Toronto, London, and Sydney. Recognized for its innovative contribution to the healthcare sector, BoomerangFX earned a spot on the Deloitte Technology Fast 500™ list for two consecutive years, reflecting its rapid growth trajectory. This new UK office aims to enhance the operational capabilities of the company and address the rising demand for advanced clinical solutions.
As part of its strategic growth, BoomerangFX announced high-level executive appointments in the UK. The company is committed to strengthening its regional leadership to facilitate further growth across Europe and EMEA. This expansion highlights a broader trend in the private healthcare sector, wherein clinics are transitioning from fragmented solutions to unified operational platforms that enhance patient acquisition, conversion, and retention.
At the core of this transformation lies BoomerangFX's flagship product, AUVIA™—an AI-powered clinical co-pilot. AUVIA™ is redefining patient engagement by efficiently linking digital demand with clinical care. The system enhances lead generation by capturing inquiries from potential patients through natural voice and text interactions. Moreover, AUVIA™ intelligently schedules appointments and follows up with patients throughout their healthcare journey, ensuring consistency and continuity in care with minimal human intervention.
The private healthcare market is at a crossroads of complexity and competitiveness, necessitating innovative operational strategies. Clinics face increasing patient acquisition costs, rising customer expectations, and a growing reliance on digital demand generation. Many fast-growing clinics still operate on disjointed systems—one for scheduling, another for electronic medical records, and varied marketing tools—resulting in data silos, lost leads, and inconsistency in patient engagement.
BoomerangFX addresses these challenges with a comprehensive platform that integrates practice management, marketing automation, and patient engagement. This unified system enables clinics to streamline operations, generate demand, and convert inquiries into booked appointments effectively.
The BoomerangFX Unified Platform
1. Practice Management + Marketing Automation + AI Acceleration
The robust operating platform tailored for private-pay clinics integrates:
- Automated Practice Management: Offers intelligent scheduling, EMR-controlled charts, electronic scripting, integrated billing with patient financing options, customizable analytics, and complete clinical workflow support.
- AI-Driven CRM and Patient Lifecycle Management: A centralized record system that delivers full visibility over care processes, unified communication across channels, intelligent segmentation, and end-to-end lifecycle management from acquisition to long-term retention.
- AI-Powered Turnkey Digital Marketing: An all-encompassing engine that drives high-performance advertising across platforms like Google and Meta, using AUVIA™ to instantly respond to incoming leads while automating follow-ups and converting inquiries into appointments.
Clinics in the UK are increasingly choosing BoomerangFX for its integrated approach to lead generation, clinic management, and patient conversion. By connecting marketing, operations, and AI-driven interactions, clinics benefit from enhanced visibility and collaboration.
Additionally, BoomerangFX integrates financial infrastructure within clinics, enhancing transaction processes and offering flexible payment options through partnerships with leading payment providers like Stripe, Klarna, and Affirm. This not only streamlines operations but also improves access to healthcare, paving the way for greater efficiency and increased revenue opportunities throughout the patient experience.
Future Investments and Leadership Growth
The accelerating expansion of BoomerangFX in the UK is primarily fueled by private-pay clinics in aesthetic medicine, medical spas, cosmetic surgery, dermatology, and other specialized sectors seeking operational leverage and predictable conversion rates. To support this momentum, the company has expanded its senior leadership team in the UK, focusing on crucial roles such as customer success and regional growth, thus enhancing on-the-ground capabilities for client onboarding, performance management, and scalability across multiple sites.
As the market evolves, clinics are moving away from disconnected tools toward cohesive systems that yield measurable results. Jerome Dwight emphasized, "Our record growth in the UK in 2025 reaffirmed our vision and the patterns we’ve observed in global markets; clinics are seeking a singular operating system that integrates operations, marketing automation, and AI-driven conversion. The new UK headquarters and the expansion of our leadership are critical investments as we continue to grow in Europe and EMEA."
Leadership in Aesthetic Technology and Business Software
BoomerangFX was co-founded by Jerome Dwight, a SaaS and fintech entrepreneur, and Dr. Stephen Mulholland, a renowned cosmetic surgeon and pioneer in non-invasive aesthetic technology. Dr. Mulholland's achievements include co-founding InMode, which went public successfully, and innovating treatments such as Morpheus8—a leading-edge radiofrequency platform pivotal in minimally invasive aesthetic treatments.
Dr. Mulholland stated, "BoomerangFX was born from the forefront of the aesthetic and private healthcare industry. Clinics demand exceptional results, but profitability and sustainability require operational precision, a consistent patient experience, and intelligent conversion. We designed BoomerangFX to provide clinics with a foundational platform to scale responsibly without compromising quality, control, or profit margins."
Sharon Flora, CEO of The Eye Retreat—a leading multidisciplinary clinic in the UK—commented on BoomerangFX’s transformative impact on her practice. With AUVIA™ implemented, her clinic has experienced significant growth, enhanced query handling, real-time consultations, and automated appointment scheduling. "It’s a modern operating system designed for performance, enabling us to scale while protecting the patient experience," she noted.
With its new UK headquarters, BoomerangFX aims to serve as a regional hub for customer success, partnerships, training, and market expansion in EMEA. As the consolidation of private healthcare groups accelerates and clinics professionalize their operations, unified platforms that integrate workflows, revenue automation, and financial infrastructure are increasingly viewed as category-defining assets.
BoomerangFX’s rapid international expansion is bolstered by industry recognition, including placements in Deloitte’s Technology Fast 50 and Fast 500 lists over the past two years. The company continues to spread its influence into emerging markets across Asia and Latin America, showcasing the need for standardized operational platforms worldwide.